|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.09.25 - 14:00
|
Commerzbank-Aktie: Fällt die Übernahme flach? (Sharedeals)
|
|
|
Die Commerzbank-Aktie befindet sich momentan in einer stärkeren Korrekturphase. Nach dem Allzeithoch Mitte August bei 37,80 € notiert sie am Dienstag aktuell bei 32,60 €. Was passiert, wenn UniCredit das Interesse verliert? UniCredit positioniert sich anderweitig Die italienische Großbank befindet sich auf einem Expansionskurs. Nachdem die Übernahme der italienischen Banco BPM an dem Veto der […]
The post Commerzbank-Aktie: Fällt die Übernahme flach? first appeared on sharedeals.de....
|
|
|
|
|
|
|
|
|
23.07.25 - 12:36
|
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. (Business Wire)
|
|
|
PIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it has secured €200 million in financing through agreements with BNL BNP Paribas, Cassa Depositi e Prestiti (CDP), and Banco BPM. These fundings are intended to support the Company's ongoing capital expenditure projects in Cisterna di Latina (Italy) and Fishers (Indiana, U.S.).
The financing agreements bolster Stevanato Group's capacity expansion efforts and the scaling of commercial production to support customers' growing biologics programs. CDP has committed €50 million to enhance the production of pre-filled syringes and set-up future capacity for ready-to-use (RTU) cartridges at Stevanato Group's Italian plant in Cisterna di Latina. Additionally, BNL BNP Paribas has provided €100 million, and Banco BPM has contributed €50 million, both aimed at scal...
|
|
|
|
|
|
|
|
|
|
|
|
|
|